SCP Vitalife Partners (Israel) II, L.P., 10% Owner at Recro Pharma, Inc. (REPH), sold 30,046 shares at $8.04 ($240K) on 2017-03-14, disclosed to the SEC on 2017-03-16.
Open-market sale of $240k REPH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.04 | 5,454 | $44K | 18.2% |
| 2 | $8.04 | 5,454 | $44K | 18.2% |
| 3 | $8.01 | 6,399 | $51K | 21.3% |
| 4 | $8.01 | 6,399 | $51K | 21.3% |
| 5 | $7.93 | 3,170 | $25K | 10.4% |
| 6 | $7.93 | 3,170 |
| $25K |
| 10.5% |
| Total | $8.00 avg | 30,046 | $240K | 100% |
| Filing → |
| REPH | SELL | 2018-01-08 | $14K | — | Filing → |
| REPH | SELL | 2018-01-04 | $230K | — | Filing → |
| REPH | SELL | 2018-01-02 | $56K | — | Filing → |